CRPC arises when prostate cancer cells adapt to the low-androgen environment. These adaptations might include the amplification of the androgen receptor (AR) gene, mutations in the AR, or the activation of alternative signaling pathways that allow cancer to grow independently of androgens. Understanding these mechanisms is crucial for developing effective treatments.
